Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11826
Outset Medical
OM
$95.8M
| $69.6K | ﹤0.01% |
18,770
-77,314
| -80% | -$663K |
|
11827
Guardforce AI
GFAI
$10.6M
| $69.3K | ﹤0.01% |
125,672
+110,366
| +721% | +$99.5K |
|
|
SRTA
11828
PUT
Strata Critical Medical Inc
SRTA
$495M
| $69.3K | ﹤0.01% |
14,400
-31,800
| -69% | -$154K |
|
|
TBI
11829
Trueblue
TBI
$313M
| $69.2K | ﹤0.01% |
+15,199
| New | +$78K |
|
|
TMQ
11830
Trilogy Metals
TMQ
$618M
| $69.2K | ﹤0.01% |
16,044
-275,716
| -95% | -$1.3M |
|
11831
Ark Restaurants
ARKR
$20.2M
| $69.1K | ﹤0.01% |
+10,312
| New | +$72K |
|
|
ACCL
11832
Acco Group Holdings
ACCL
$39.9M
| $69.1K | ﹤0.01% |
+25,511
| New | +$92.7K |
|
11833
CALL
ProQR Therapeutics
PRQR
$277M
| $69.1K | ﹤0.01% |
+34,200
| New | +$79.9K |
|
|
AUC
11834
ATIF Holdings
AUC
$72.8M
| $69K | ﹤0.01% |
+12,280
| New | +$97.3K |
|
11835
CALL
Valens Semiconductor
VLN
$181M
| $69K | ﹤0.01% |
48,600
+6,200
| +15% | +$10.2K |
|
11836
PUT
Orchestra BioMed
OBIO
$243M
| $68.9K | ﹤0.01% |
+16,600
| New | +$67K |
|
|
ORGN
11837
PUT
DELISTED
Origin Materials
ORGN
| $68.7K | ﹤0.01% |
10,823
+1,510
| +16% | +$22K |
|
|
IVA
11838
Inventiva
IVA
$1.1B
| $68.3K | ﹤0.01% |
+14,699
| New | +$68.3K |
|
11839
PUT
Stereotaxis
STXS
$136M
| $68.3K | ﹤0.01% |
29,700
+9,500
| +47% | +$25.3K |
|
11840
PUT
Douglas Elliman
DOUG
$162M
| $68.3K | ﹤0.01% |
+28,800
| New | +$74.1K |
|
11841
Rockwell Medical
RMTI
$28.8M
| $68.3K | ﹤0.01% |
+8,189
| New | +$82.6K |
|
11842
CALL
KORU Medical Systems
KRMD
$164M
| $68K | ﹤0.01% |
+11,700
| New | +$56K |
|
11843
PUT
Pyxis Oncology
PYXS
$217M
| $68K | ﹤0.01% |
+59,100
| New | +$208K |
|
11844
PUT
Safe Bulkers
SB
$791M
| $68K | ﹤0.01% |
14,100
+2,000
| +17% | +$9.49K |
|
|
NWGL
11845
CL Workshop Group Ltd
NWGL
$4.79M
| $67.9K | ﹤0.01% |
47,484
+8,129
| +21% | +$10.9K |
|
|
EDF
11846
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$169M
| $67.9K | ﹤0.01% |
+13,657
| New | +$67.2K |
|
11847
PUT
PetMed Express
PETS
$42.3M
| $67.8K | ﹤0.01% |
21,200
-2,600
| -11% | -$6.52K |
|
11848
Armata Pharmaceuticals
ARMP
$172M
| $67.7K | ﹤0.01% |
+10,786
| New | +$59.1K |
|
|
ZTR
11849
Virtus Total Return Fund
ZTR
$339M
| $67.7K | ﹤0.01% |
+10,750
| New | +$69.3K |
|
11850
Toro Corp
TORO
$183M
| $67.2K | ﹤0.01% |
12,735
-12,653
| -50% | -$54.8K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.